Everything on Pharmaceutical Strategy

Novartis faces substantial revenue declines due to US patent expirations, with key drug sales dropping 40-65% as generics enter the market.

Impact: Underscores the critical need for robust pipeline development and strategic acquisitions to offset patent cliff impacts.

— from Market Shifts: AI Costs, Pricing Strategies, and Sector Realignment · OHNE AKTIEN WIRD SCHWER - Tägliche Börsen-News· Apr 29, 2026